| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,105 | 7,534 | 7,071 | 5,979 | | Cost of Revenue | 5,643 | 5,427 | 5,626 | 4,633 | | | Gross Profit | 1,462 | 2,107 | 1,445 | 1,347 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,036 | 4,027 | 4,094 | 5,177 | | Non Recurring |
-
|
-
|
-
| (170) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,504) | (1,920) | (2,649) | (3,661) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (21) | 21 | 83 | | Earnings Before Interest And Taxes | (1,569) | (1,941) | (2,628) | (3,578) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,569) | (1,941) | (2,628) | (3,578) | | Income Tax Expense | (87) | 26 | (27) | (189) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,482) | (1,967) | (2,601) | (3,389) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,482) | (1,967) | (2,601) | (3,389) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,482) | ($1,967) | ($2,601) | ($3,389) |
|
0.11% Nasdaq 0.00%
Income Statement
